ClariVest Asset Management LLC lowered its position in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 2.1% during the second quarter, Holdings Channel reports. The institutional investor owned 153,635 shares of the medical device company’s stock after selling 3,360 shares during the period. Cooper Companies, Inc. (The) makes up about 0.9% of ClariVest Asset Management LLC’s holdings, making the stock its 27th largest position. ClariVest Asset Management LLC’s holdings in Cooper Companies, Inc. (The) were worth $36,783,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of COO. Creative Planning increased its position in shares of Cooper Companies, Inc. (The) by 0.8% in the second quarter. Creative Planning now owns 1,909 shares of the medical device company’s stock worth $457,000 after buying an additional 16 shares in the last quarter. CIBC Asset Management Inc increased its position in shares of Cooper Companies, Inc. (The) by 0.3% in the second quarter. CIBC Asset Management Inc now owns 4,697 shares of the medical device company’s stock worth $1,125,000 after buying an additional 16 shares in the last quarter. Wedbush Securities Inc. increased its position in shares of Cooper Companies, Inc. (The) by 1.0% in the second quarter. Wedbush Securities Inc. now owns 1,783 shares of the medical device company’s stock worth $427,000 after buying an additional 18 shares in the last quarter. Genesee Valley Trust Co. increased its position in shares of Cooper Companies, Inc. (The) by 1.1% in the first quarter. Genesee Valley Trust Co. now owns 1,957 shares of the medical device company’s stock worth $391,000 after buying an additional 21 shares in the last quarter. Finally, Pacer Advisors Inc. increased its position in shares of Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock worth $170,000 after buying an additional 31 shares in the last quarter. Institutional investors and hedge funds own 99.97% of the company’s stock.

Cooper Companies, Inc. (NYSE COO) opened at 240.92 on Friday. The stock has a market cap of $11.77 billion, a P/E ratio of 36.12 and a beta of 0.61. Cooper Companies, Inc. has a 52 week low of $158.73 and a 52 week high of $256.39. The firm has a 50-day moving average price of $245.14 and a 200-day moving average price of $214.89.

Cooper Companies, Inc. (The) (NYSE:COO) last released its earnings results on Thursday, June 1st. The medical device company reported $2.50 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.25 by $0.25. The firm had revenue of $522.40 million during the quarter, compared to analysts’ expectations of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The company’s revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.05 EPS. On average, equities research analysts predict that Cooper Companies, Inc. will post $9.63 EPS for the current year.

The company also recently announced a semiannual dividend, which was paid on Monday, August 7th. Shareholders of record on Friday, July 21st were issued a dividend of $0.03 per share. This represents a yield of 0.02%. The ex-dividend date was Wednesday, July 19th. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is presently 0.90%.

TRADEMARK VIOLATION WARNING: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2017/08/12/cooper-companies-inc-the-coo-shares-sold-by-clarivest-asset-management-llc.html.

A number of research analysts have recently weighed in on the company. Oppenheimer Holdings, Inc. set a $225.00 price target on Cooper Companies, Inc. (The) and gave the company a “hold” rating in a report on Saturday, June 3rd. Guggenheim began coverage on Cooper Companies, Inc. (The) in a report on Thursday, June 29th. They set a “neutral” rating on the stock. Jefferies Group LLC restated a “buy” rating and issued a $250.00 target price on shares of Cooper Companies, Inc. (The) in a research note on Thursday, July 6th. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $274.00 target price on the stock in a research note on Friday, June 23rd. Finally, Stifel Nicolaus boosted their target price on Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the company a “buy” rating in a research note on Friday, June 2nd. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Cooper Companies, Inc. (The) has an average rating of “Buy” and a consensus target price of $242.00.

In other Cooper Companies, Inc. (The) news, CEO Paul L. Remmell sold 9,294 shares of the stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the completion of the transaction, the chief executive officer now owns 6,186 shares in the company, valued at approximately $1,536,973.56. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Randal Golden sold 1,621 shares of the stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $243.65, for a total value of $394,956.65. Following the transaction, the vice president now owns 1,731 shares of the company’s stock, valued at approximately $421,758.15. The disclosure for this sale can be found here. In the last quarter, insiders have sold 67,331 shares of company stock valued at $16,400,454. Corporate insiders own 1.60% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.